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Abstract Background Medicines reconciliation—identi-
fying and maintaining an accurate list of a patient’s current
medications—should be undertaken at all transitions of care
and available to all patients. Objective A self-completion
web survey was conducted for chief pharmacists (or equiv-
alent) to evaluate medicines reconciliation levels in sec-
ondary care mental health organisations. Setting The survey
was sent to secondary care mental health organisations in
England, Scotland, Northern Ireland and Wales.MethodThe
survey was launched via Bristol Online Surveys. Quantita-
tive data was analysed using descriptive statistics and qual-
itative data was collected through respondents free-text
answers to specific questions. Main outcomes measure
Investigate how medicines reconciliation is delivered,
incorporate a clear description of the role of pharmacy staff
and identify areas of concern. Results Forty-two (52 %
response rate) surveys were completed. Thirty-seven
(88.1 %) organisations have a formal policy for medicines
reconciliation with defined steps. Results show that the
pharmacy team (pharmacists and pharmacy technicians) are
the main professionals involved in medicines reconciliation
with a high rate of doctors also involved. Training proce-
dures frequently include an induction by pharmacy for
doctors whilst the pharmacy team are generally trained by
another member of pharmacy. Mental health organisations
estimate that nearly 80 % of medicines reconciliation is
carried out within 24 h of admission. A full medicines rec-
onciliation is not carried out on patient transfer between
mental health wards; instead quicker and less exhaustive
variations are implemented. 71.4 % of organisations esti-
mate that pharmacy staff conduct daily medicine reconcili-
ations for acute admission wards (Monday to Friday).
However, only 38 % of organisations self-report to phar-
macy reconciling patients’ medication for other teams that
admit from primary care. Conclusion Most mental health
organisations appear to be complying with NICE guidance
on medicines reconciliation for their acute admission wards.
However, medicines reconciliation is conducted less fre-
quently on other units that admit from primary care and
rarely completed on transfer when it significantly differs to
that on admission. Formal training and competency assess-
ments on medicines reconciliation should be considered as
current training varies and adherence to best practice is
questionable.
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Impacts of findings on practice
• The majority of secondary care mental health organi-
sations appear to be complying to NICE guidance as
nearly 80 % of organisations are carrying out medicines
reconciliation within 24 h of admission on acute wards.
• Medicines reconciliation on patients admitted via crisis
and home treatment teams is an area where further
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research and guidelines are needed as only 38 % of
organisations report carrying it out.
• Medicines reconciliation on transfer is currently much
quicker and less exhaustive to the process on
admission.
• Methods of staff training on medicines reconciliation
currently differ between all trusts. There is doubt on its
adherence to clinical excellence, as this research has
shown there frequently are no formal training proce-
dures put in place by the trusts.
Introduction
Precise and trustworthy information about patient medi-
cation, including how well they are adhering to their
medication regimen, must be obtained every time a patient
is transferred from one healthcare setting to another [1].
This includes: names, dosages, frequencies, and routes of
administration, allowing healthcare professionals to com-
pare the patient’s previous medication list with their cur-
rent medication list [2–4]. Timely and informed decisions
can then be made regarding the patient’s future treatment
and any discrepancies can be accounted for, documented
and dealt with appropriately [1, 5]. This is the process of
medicines reconciliation [1–5].
Accuracy and promptness in completing medicines
reconciliation decreases the risk of medication errors being
made in primary and secondary care, when transferring
across these boundaries as well as when transferring within
them [4]. In 2007, Medicines Reconciliation guidelines
were published by The National Institute for Health and
Care Excellence (NICE) in collaboration with the National
Patient Safety Agency (NPSA), identifying the aim of the
process: to confirm that medicines prescribed upon
admission correlate to those taken by the patient prior to
admission in order to reduce adverse drug events [4, 5].
More recent NICE guidance [6] and World Health
Organisation (WHO) guidance [7] suggest medicines rec-
onciliation should be completed within 24 h of admission.
The recent NICE guidance also identified that the process
may need to be carried out more than once during the
admission, for example on transfer between wards [6].
Additionally all relevant information must be documented
on paper or electronically [6].
In this study, a national survey on the practise of
medicines reconciliation in mental health organisations
was completed by chief pharmacists or those with equiv-
alent status. The survey was specifically sent out to
members of the College of Mental Health Pharmacy
(CMHP), a UK organisation dedicated to advancing
education and promoting research in the practice of mental
health pharmacy for the benefit of the public.
Traditionally, junior doctors have had the responsibility
of undertaking medicines reconciliation, increasingly this
is becoming a pharmacist and pharmacy technician’s role
[5, 8]. Recent guidance by NICE states there should be a
designated healthcare professional that carries overall
responsibility for the process and it should be undertaken
by trained, competent health professionals—ideally phar-
macists, pharmacy technicians, nurses or doctors [6]. This
study explores the role of each staff member, with a
principal focus on the pharmacy team (both pharmacists
and pharmacy technicians) and the variability of the pro-
cedure between organisations providing secondary care
mental health services.
Primary care is the usual first point of contact for
healthcare within the NHS and includes GP services. Sec-
ondary care refers to specialist services, which are usually
accessed following a referral from primary care. Secondary
care mental health services include in-patient wards and
community teams, such as crisis and home treatment teams,
which typically provide intensive support, in the commu-
nity, for people suffering from a mental health crisis.
People with mental health problems may be particularly
susceptible to medicine reconciliation discrepancies due to
their highly complicated conditions and drug regimes, as
well as the impact of cognitive impairment [8–10]. The
pharmacy team has a key role in reducing reconciliation
errors within hospital and mental health settings [5, 10, 11].
Very few studies have analysed the process of medicines
reconciliation at admission in mental health organisations
[5, 12]. Data collected will aid healthcare providers and
patients in understanding how the service is delivered by
organisations providing secondary mental health care and
the role of pharmacists and pharmacy technicians.
Medicines reconciliation has been proven to reduce drug
regime discrepancies in prior studies [5, 10, 11], and
ensuring that the process is undertaken regularly and fully
will benefit patient safety.
Aim
To investigate how medicines reconciliation is delivered
within organisations providing mental health services
across England, Northern Ireland, Scotland and Wales.
The objectives were:
1. To identify how and when medicines reconciliation is
undertaken within various mental health organisations
as well as the role of each staff member in the process
and novel approaches to support prospective guidance.
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2. To identify the level at which organisations providing
secondary care mental health services are compliant
with NICE guidance [5].
Ethical approval
Ethical approval from Aston University’s research and
ethics committee (pharmacy sub-committee) was obtained.
Methods
Medicines reconciliation procedures were thoroughly
researched using published literature in order to construct
appropriate questions for the online self-completion web
survey. Questions were discussed and developed between
all authors. Questions were then loaded onto the web via
Bristol Online Surveys (BOS). The survey was divided into
sections pertaining to the respondent, their trust, the
medicines reconciliation process, the role of pharmacy,
medicines reconciliation on transfer and discharge, targets,
discrepancies and an area for further comments respon-
dents would like to make. Each part had a series of relevant
open and closed questions in a variety of styles including:
single one best answer multiple choice, multiple answer
multiple choice, free-text multiple line format questions
and ranking questions (Appendix of Supplementary mate-
rial). One question was displayed per page.
Upon loading the survey online, a pilot test was sent out.
A chief, directorate and lead mental health pharmacist from
three different mental health trusts, either from England or
Wales piloted the survey. The final survey incorporated the
changes as suggested from the pilot work.
The survey was then launched to chief pharmacists (or
equivalent) in organisations providing secondary care
mental health services via BOS in 2014. An email high-
lighting the purpose of the project and a link directing
applicants to the BOS website displaying the survey was
sent to eight senior or chief pharmacists that had volun-
teered from each region of the UK (North, East, South and
West England, London, Scotland, Wales, and Northern
Ireland). They then forwarded this email to chief pharma-
cists or professionals of equivalent status in all mental
health organisations within their region. Volunteer senior
or chief pharmacists were used in preference to emailing
organisations directly from an unknown student, in an
attempt to improve the response rate. Additionally, the
email and survey link was sent to the CMHP email dis-
cussion group, to remind the participants about the study
and thus also to improve the response rate. A list of
organisations providing mental health services within each
region was obtained online in order to keep record of
responses and determine a response rate [13–17].
The survey was open for 4 weeks; participants were sent
weekly reminder emails from the eight volunteer senior or
chief pharmacists from each region, members of the CMHP
email discussion group were also sent weekly reminder
emails. Participants were able to save and complete the
survey at a later time whilst the survey was open.
The following definition of medicines reconciliation was
set to aid participants in completing the survey questions:
Medicines reconciliation is the process of identifying
and maintaining an accurate list of a patient’s current
medications (including name, dosage, frequency, and
route). A minimum of two sources must be used to
confirm the medication a patient was prescribed prior
to admission. E.g. from the GP surgery and carer. The
process is only complete if no discrepancies are found
or when discrepancies found are resolved [5].
Throughout the data-collection stage, a log of each
respondent’s answers was obtained via the BOS pro-
gramme allowing for the full data set to be obtained on
closure of the survey. BOS automatically calculates sta-
tistical values including the mean, confidence intervals,
lower and upper quartiles for each question in the survey.
Quantitative data was analysed using descriptive statistics,
whilst qualitative data involved scrutinising all free-text




Only one response from each organisation was required.
However, in two cases two chief pharmacists (or equiva-
lent) each completed the survey. These responses were
compared to each other, and as the answers were broadly
similar the answers from the participant rendering more
detail throughout his/her answers were included. The other
two results were discarded confidentially. As two sets of
results were taken out from the data set, all statistical
measures had to be re-calculated by hand.
Basic descriptive statistics were used to quantify the
percentages of persons providing specific answers. A total
of 44 responses were obtained, however only 42 were used
in analysis due to the multiple surveys received from two
organisations. The response received by each country and
their corresponding response rates are shown in Table 1
below. The overall response rate is 51.9 %.
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Formal policies and protocols
Thirty-seven of the mental health organisations (88.1 %)
have a formal policy or protocol for medicines reconcili-
ation on admission of patients, whilst five (11.9 %) do not.
Of those with a formal policy or protocol for medicines
reconciliation, 36 organisations (97.3 %) state that the
formal policy also defined what steps are to be taken in
medicines reconciliation (Fig. 1).
Time frames
Thirty-nine (92.9 %) organisations reported they have a
time scale in which to complete reconciliations. Of the 39
organisations with a target time frame, 18 organisations
(46.2 %) aim for completing medicines reconciliation
within 24 h, 3 more organisations (total 21 organisations,
53.8 %) within 48 h, 17 more organisations (total 38
organisations, 97.4 %) within 72 h and one more organi-
sation (total 39 organisations, 100 %) within 1 week.
77.1 % of mental health organisations estimate they com-
plete medicines reconciliation by 5 pm the day following
admission. In 24, 48, 72 h and 1 week following
admission; 79.3, 84.6, 89.8 and 97.6 % of mental health
organisations estimate medicines reconciliations to be
achieved respectively (Table 2).
Acute, non-acute admission wards and teams
admitting from primary care
Thirty respondents (71.4 %) said members of pharmacy
staff carry out medicines reconciliation daily (excluding
weekends and bank holidays) on acute admission wards. Of
the 12 organisations (28.6 %) that do not carry out
medicines reconciliation daily on acute admission wards,
five organisations (41.7 %) indicated the service is deliv-
ered once per week or less on acute admission wards, 2
organisations (16.7 %) twice per week, 4 organisations
(33.3 %) three times per week and one organisation
(8.3 %) four times per week. Participants were also asked
if any members of pharmacy staff carry out medicines
reconciliation for any other teams that admit patients from
primary care (e.g. crisis teams, home treatment teams).
Sixteen organisations (38.1 %) answered yes; data on fre-
quency was not obtained.
A total of 39 organisations reported pharmacy members
carry out medicines reconciliation on non-acute admission
wards compared to three organisations answering ‘not
applicable’ to the survey question. Of the 39 organisations,
seventeen organisations (40.5 %) said pharmacy members
carry out medicines reconciliation daily (excluding week-
ends and bank holidays). Of the remaining 22 organisations
(52.4 %) not completing it daily, 14 organisations (63.6 %)
said it is done once per week or less on non-acute admis-
sion wards, 4 organisations (18.2 %) twice per week and 4
organisations (18.2 %) three times per week.
Medicines reconciliation on transfer
Twenty-two organisations (52.4 %) do not undertake
medicines reconciliation when patients are moved inter-
nally within their trust. Free-text answers reveal medicines
reconciliation on transfer differs from admission because it
Table 1 Response rate to survey
England Scotland Wales Northern
Ireland
Total
Number of mental health organisations
that responded (percentage out of
total responses)
31 (73.8 %) 9 (21.4 %) 2 (4.7 %) 0 (0 %) 42
Response rate per region 55.4 % (31 of 56) 64.3 % (9 of 14) 33.3 % (2 of 6) 0 % (0 of 5) 51.9 % (42 of 81)
The first row represents the number of mental health organisations within each region that completed the survey and the percentage that region
makes up for out of total responses. The second row represents the response rates within each region surveyed as well as the total response rate of
all regions combined
42 organisations 
providing secondary care 
mental health services 
surveyed
37 (88.1%) do have a 




36 (97.3%) state that the 
formal policy defines 
what steps are to be taken 
in medicines 
reconciliation
1 (2.7%) state that the 
formal policy does not
define what steps are to 
be taken in medicines 
reconciliation
5 (11.9%) do not have a 




Fig. 1 Number of mental health organisations with policies and
procedures
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is a ‘‘quick check that it has been done on admission, all
changes since admission are noted and clear.’’
Staff roles
95.2 % of responses indicated pharmacists were account-
able for delivering medicines reconciliation and 71.4 %
pharmacy technicians involved in the process. Doctors and
nurses were 66.7 and 42.9 % respectively accountable for
undertaking the procedure.
Staff training
Respondents were asked to indicate what type of training
each healthcare professional receives (Fig. 2). Sixteen
organisations selected ‘other’ for doctors. Free-text
answers indicate ‘‘doctors are trained during induction by
the pharmacy team.’’ Thirty-three organisations and 17
organisations respectively indicated pharmacists and
pharmacy technicians are trained by learning from another
member of staff. Free-text answers in response to ‘other’
methods included ‘‘supervised or observed assessment.’’
Results indicate the pharmacy team usually learns via
another staff member and they are not receiving any formal
form of training or assessment before completing medici-
nes reconciliation or training doctors. Four organisations
indicated either close supervision or observed assessment
for pharmacists. A total of 26 organisations said pharmacy
technicians complete an in-house course or attend an
accredited course external to their organisation whereas
seven organisations have pharmacists undertake an in-
house course and none are sent for an external course.
Discussion
Almost 80 % of organisations appear to be completing
medicines reconciliation, on their acute admission wards,
within 24 h of admission in line with NICE and WHO
guidance [5–7], however only 46.2 % set a target of having
Table 2 Timeframes
Time frame Number of organisations aiming for the
time frame (percentage aiming for the
indicated time frame or shorter)
Percentage of organisations reaching
the time frame (completing
medicines reconciliation within the
time frame) (%)
5 pm the day after admission 0 % 77.1
24 h 18 (46.2 %) 79.3
48 h 3 (53.8 %) 84.6
72 h 17 (97.4 %) 89.8
Up to 1 week 1 (100 %) 97.6
The second column represents each organisations target time frame for medicines reconciliation to be completed in their policy. The percentage
figures in this column represent the percentage of organisations aiming for the indicated target or shorter time frame. The final column is
estimated percentages of organisations completing medicines reconciliations within the specified time frame from survey results
Fig. 2 Medicines reconciliation
training for healthcare
professionals. Response totals
are above 42 as more than one
option could be selected by the
respondent
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the process completed within 24 h. The reasons for these
variations are not clear. Supporting organisations to aim for
a higher percentage within 24 h may be practical and could
be very beneficial to the system. Achieving faster rates can
be encouraged via Commissioning for Quality and Inno-
vation (CQUIN) payment framework, contractual perfor-
mance measures, Key Performance Indicators (KPI) targets
or the Scottish Patient Safety Programme for Mental
Health.
Establishments that do not have daily pharmacy visits
and low reconciliation levels throughout the week should
consider improvements in the medicines reconciliation
process. Some mental health organisations that are unable
to have daily pharmacist visits to every ward had lower
reconciliation levels; however it did not show a direct
correlation through this study’s results.
Generally, pharmacy staff is not conducting medicines
reconciliation for other units that admit from primary care
(such as crisis and home treatment teams). The recent
NICE guidance highlighted the need for medicines recon-
ciliation when patients are transferred between wards [6].
This research found that medicines reconciliation on
transfer is generally much quicker and less exhaustive than
on admission. It ‘‘is not as rigorous, it’s an accuracy check
of any changes since admission rather than a full recon-
ciliation of the entire medication history.’’ However, the
care is still within the mental health organisation; hence the
responsibility continues to lie within the organisation pro-
viding the care.
Both NICE and WHO highlight the importance of staff
training [6, 7]. The lack of formal training, particularly for
pharmacy staff, may raise concerns that medicines recon-
ciliation is not creating an environment of clinical excel-
lence. However, it must be noted that many of these
organisations have introduced medicines reconciliation
without any extra funding.
Earlier research has identified that medication errors are
common when people with mental health problems move
between primary and secondary care mental health services
[8, 19, 20]. Previous studies in the UK and America have
confirmed medicines reconciliation is effective in reducing
medication errors within hospital admission wards, emer-
gency departments and mental health trusts [8, 11, 12]. A
recent audit-based quality improvement programme had
focussed on medicines reconciliation on admission to in-
patient psychiatric care in the UK. The audit had data
submitted for 1790 patients from 42 trusts at baseline and
2296 patients from 43 trusts at re-audit (16 months later)
[21]. Like our research, the audit found most medicine
reconciliations were conducted by pharmacy staff and
occurred within 24 h of admission [21]. Specifically, the
audit found that at baseline and at re-audit, pharmacy staff
(pharmacist or pharmacy technician) were involved in
1251 (70 %) and 1902 (83 %) of patients’ medicine rec-
onciliations respectively [21].
This research found that most organisations do not have
members of the pharmacy team reconciling medication on
units other than acute admission wards, for example crisis
teams that admit directly from primary care. This is in
contrast with acute admission wards. These other units are
an increasingly important link between primary and sec-
ondary care, and it is vital that medicines reconciliation
services are delivered regularly and accurately to these
units, as well as to acute admission wards. Organisations
may need to focus on enhancing this service within these
units to improve patient safety. Mental health organisations
should also consider introducing formal training pro-
grammes for pharmacy staff involved in medicines recon-
ciliation perhaps as part of the pharmacy department’s
training programme.
Further research should investigate the actual level of
medicines reconciliation, in contrast to self-reported levels,
delivered by both pharmacy staff and other clinicians to all
units that admit from primary care. Work should also focus
on developing the role of pharmacy in medicines recon-
ciliation within other units that admit from primary care
and during transfer between units within the organisation,
as well as the impact of such services on medication safety
and other key clinical outcomes. Finally, validated training
programmes for pharmacy staff should be developed.
Limitations of the study include:
1. The overall response rate was 51.9 % therefore the
results should be interpreted with some caution.
2. All responses were self-reported by respondents and
the study did not aim to identity the accurate level of
services.
3. The survey focussed on services delivered by members
of the pharmacy team.
4. No responses were obtained from Northern Ireland;
therefore the research cannot necessarily be extrapo-
lated to the whole of the UK.
5. The survey did not question the rate of medicine
reconciliations being carried out throughout the week-
end and any holidays. However with lower staff
numbers on weekends and holidays, it is likely the rate
of reconciliations would be low which could be
hazardous to patient health safety.
6. In survey questions asking how often medicines
reconciliation is carried out on acute and non-acute
admission wards, there was no option to select ‘‘zero’’
times per week. Majority of respondents selected the
once weekly option, however it may be possible that
the better suited answer would have been zero times
per week for these mental health organisations and
there was no way to specify this.
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Conclusions
Numerous studies have been completed within hospitals on
medicines reconciliation, however this study is one of few
concerning organisations providing secondary care mental
health services within the UK. This survey study has
established a background to how medicines reconciliation
is currently delivered in mental health wards and has raised
some areas of concern in which additional research should
be carried out. Overall, NICE guidance is relatively well
implemented as nearly 80 % of mental health organisations
report conducting medicines reconciliation within 24 h of
admission on acute admission wards (excluding weekends
and holidays). However, increasingly people with mental
health problems are admitted to secondary organisations
via crisis or home treatment teams and only 38 % of
organisations self-report to reconciling the medicines of
these patients.
The impact of current staff training procedures and how
well they adhere to best practice without formal training,
suggests pharmacy departments need to consider formal
training and competency assessments for the pharmacy
team. As results indicated medicines reconciliation on
transfer is rarely completed and when it is, the process
significantly differs to that on admission; secondary care
mental health organisations should consider appropriate
guidelines for transfer and whether a full reconciliation of
medicines is compulsory or not.
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